Major ozone therapy improves disease severity without affecting retinal microvascular parameters in fibromyalgia syndrome: an observational pre-post study
Burhan Fatih Kocyigit, Gülşah Yaşa Öztürk, Duygu Topaktaş Emekli, Eda Sahutoglu · 2026
Read Major ozone therapy improves disease severity without affecting retinal microvascular parameters in fibromyalgia syndrome: an observational pre-post study by Burhan Fatih Kocyigit, Gülşah Yaşa Öztürk, Duygu Topaktaş Emekli, Eda Sahutoglu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13198504.txt.
Description
Burhan Fatih Kocyigit and colleagues tested ozone therapy in fibromyalgia, tracking both symptoms and eye vessels, in a 2026 study. Fibromyalgia causes wide pain and fatigue. Major ozone therapy mixes a patient's blood with ozone gas before return, and some claim broad gains, so proof on safety matters.
Thirty patients got ten weekly sessions at a large hospital. A standard impact score fell sharply after treatment, marking a lighter symptom load. Eye checks were thorough: vision, pressure, cornea thickness, and fine retinal vessel scans. None of those measures shifted in a meaningful way. The authors read the result as symptom gain without eye vessel harm, in a study with no control group.
Catalog record
| CREATOR | Burhan Fatih Kocyigit, Gülşah Yaşa Öztürk, Duygu Topaktaş Emekli, Eda Sahutoglu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |